Differential expression of the Ly49GB6, but not the Ly49GBALB, receptor isoform during natural killer cell reconstitution after hematopoietic stem cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 10, 2013, Pages 1446-1452

  Barao, Isabel ^a   Wright, Paul W ^b   Sungur, Can M ^c   Anderson, Stephen K ^b   Redelman, Doug ^a   Murphy, William J ^c  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hematopoietic stem cell transplantation; Ly49G; Natural killer cell

Indexed keywords

CELL RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; RECEPTOR;

ALLELE; ANIMAL CELL; ARTICLE; FEMALE; GENE; GENETIC POLYMORPHISM; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HYBRID; MOUSE; NATURAL KILLER CELL; NONHUMAN;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; LY49G; NATURAL KILLER CELL;

ANIMALS; ANTIGENS, LY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTEIN ISOFORMS; TRANSFECTION; TRANSPLANTATION CONDITIONING;

EID: 84884171253     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.07.021     Document Type: Article

References (29)

1. Ljunggren H.G., Karre K. In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today 1990, 11:237-244.
2. Raulet D.H., Vance R.E. Self-tolerance of natural killer cells. Nat Rev Immunol 2006, 6:520-531.
3. Anfossi N., Andre P., Guia S., et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006, 25:331-342.
4. Kim S., Poursine-Laurent J., Truscott S.M., et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005, 436:709-713.
5. Joncker N.T., Fernandez N.C., Treiner E., et al. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. JImmunol 2009, 182:4572-4580.
6. Raulet D.H., Vance R.E., McMahon C.W. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001, 19:291-330.
7. Held W., Coudert J.D., Zimmer J. The NK cell receptor repertoire: formation, adaptation and exploitation. Curr Opin Immunol 2003, 15:233-237.
8. Fernandez N.C., Treiner E., Vance R.E., et al. Asubset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005, 105:4416-4423.
9. Chalifour A., Scarpellino L., Back J., et al. ARole for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 2009, 30:337-347.
10. Ruggeri L., Mancusi A., Capanni M., et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood 2007, 110:433-440.
11. + NK cells dominate early responses during both immune reconstitution and activation independently of MHC. Blood 2011, 117:7032-7041.
12. Orr M.T., Murphy W.J., Lanier L.L. "Unlicensed" natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol 2010, 11:321-327.
13. Raziuddin A., Longo D.L., Bennett M., et al. Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens. Blood 2002, 100:3026-3033.
14. Ortaldo J.R., Mason A.T., Winkler-Pickett R., et al. Ly-49 receptor expression and functional analysis in multiple mouse strains. JLeukoc Biol 1999, 66:512-520.
15. Makrigiannis A.P., Rousselle E., Anderson S.K. Independent control of Ly49g alleles: implications for NK cell repertoire selection and tumor cell killing. JImmunol 2004, 172:1414-1425.
16. Saleh A., Davies G.E., Pascal V., et al. Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukariotic mechanism for selective gene activation. Immunity 2004, 21:55-66.
17. Johansson S., Johansson M., Rosmaraki E., et al. Natural killer celleducation in mice with single or multiple major histocompatibility complex class I molecules. JExp Med 2005, 201:1145-1155.
18. Mason L.H., Ortaldo J.R., Young H.A., et al. Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2). JExp Med 1995, 182:293-303.
19. Hanke T., Takizawa H., McMahon C.W., et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 1999, 11:67-77.
20. Tanamachi D.M., Hanke T., Takizawa H., et al. Expression of natural killer receptor alleles at different Ly49 loci occurs independently and is regulated by major histocompatibility complex class I molecules. JExp Med 2001, 193:307-315.
21. Miller J.S., Soignier Y., Panoskaltsis-Mortari A., et al. Successful adoptive transfer and invivo expansion of human haploidentical NK cells in patients with cancer. Blood 2005, 105:3051-3057.
22. Cooper M.A., Bush J.E., Fehniger T.A., et al. Invivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 2002, 100:3633-3638.
23. Raulet D.H., Held W., Correa I., et al. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 1997, 155:41-52.
24. Li H., Pascal V., Martin M.P., et al. Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet 2008, 11:1-11.
25. Diefenbach A., Raulet D.H. Strategies for target cell recognition by natural killer cells. Immunol Rev 2001, 181:170-184.
26. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005, 5:201-214.
27. Yu J., Venstrom J.M., Liu X.R., et al. Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation. Blood 2009, 113:3875-3884.
28. Fuchs E.J., Huang X.J., Miller J.S. HLA-haploidentical stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant 2010, 16:S57-S63.
29. Wilson M.J., Torkar M., Haude A., et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA 2000, 97:4778-4783.